These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2146062)

  • 1. Pathogenesis of diabetic neuropathy: the role of the n-6 essential fatty acids and their eicosanoid derivatives.
    Jamal GA
    Diabet Med; 1990 Aug; 7(7):574-9. PubMed ID: 2146062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy.
    Jamal GA
    Diabet Med; 1994 Mar; 11(2):145-9. PubMed ID: 8200197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of essential fatty acids in the development of diabetic neuropathy and other complications of diabetes mellitus.
    Horrobin DF
    Prostaglandins Leukot Essent Fatty Acids; 1988; 31(3):181-97. PubMed ID: 3047752
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy.
    Cameron NE; Cotter MA
    Diabetes; 1997 Sep; 46 Suppl 2():S31-7. PubMed ID: 9285496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications.
    Cameron NE; Cotter MA
    Diabetes Metab Rev; 1994 Oct; 10(3):189-224. PubMed ID: 7835170
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of prostaglandins, leukotrienes and essential fatty acids in the pathogenesis of the complications associated with diabetes mellitus.
    Mikhailidis DP; Jeremy JY; Dandona P
    Prostaglandins Leukot Essent Fatty Acids; 1988; 33(3):205-6. PubMed ID: 3070569
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral diabetic neuropathy and polyunsaturated fatty acid supplementations: natural sources or biotechnological needs?
    Coste TC; Gerbi A; Vague P; Maixent JM; Pieroni G; Raccah D
    Cell Mol Biol (Noisy-le-grand); 2004 Nov; 50(7):845-53. PubMed ID: 15672469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of abnormalities in nerve metabolism in the pathogenesis of diabetic peripheral neuropathy.
    Clements RS
    Ala J Med Sci; 1976 Oct; 13(4):399-404. PubMed ID: 185920
    [No Abstract]   [Full Text] [Related]  

  • 9. Essential fatty acids and their metabolites in signal transduction.
    Wood JN
    Biochem Soc Trans; 1990 Oct; 18(5):785-6. PubMed ID: 1707376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.
    Cameron NE; Eaton SE; Cotter MA; Tesfaye S
    Diabetologia; 2001 Nov; 44(11):1973-88. PubMed ID: 11719828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
    Cameron NE; Cotter MA
    Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential fatty acids/eicosanoid biosynthesis in the skin: biological significance.
    Ziboh VA
    Proc Soc Exp Biol Med; 1994 Jan; 205(1):1-11. PubMed ID: 8115346
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of growth hormone in the pathogenesis of vascular complications of diabetes mellitus.
    Rehman HU
    Am J Med Sci; 2000 Aug; 320(2):128-34. PubMed ID: 10981489
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic abnormalities contributing to diabetic complications. I. Glucose metabolism in insulin-insensitive pathways.
    Anderson JW
    Am J Clin Nutr; 1975 Mar; 28(3):273-80. PubMed ID: 123410
    [No Abstract]   [Full Text] [Related]  

  • 15. Biosynthesis of prostaglandins.
    Lands WE
    Annu Rev Nutr; 1991; 11():41-60. PubMed ID: 1892707
    [No Abstract]   [Full Text] [Related]  

  • 16. Abnormalities of glomerular eicosanoid metabolism in states of glomerular hyperfiltration.
    Schambelan M; Don BR; Kaysen GA; Blake S
    Adv Exp Med Biol; 1989; 259():275-304. PubMed ID: 2696356
    [No Abstract]   [Full Text] [Related]  

  • 17. Psoriasis: current concepts and new approaches to therapy.
    Das UN; Vijaykumar K; Madhavi N; Suryaprabha P; Sravankumar G; Ramesh G; Koratkar R; Sagar PS; Padma M
    Med Hypotheses; 1992 May; 38(1):56-62. PubMed ID: 1319539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of diabetic neuropathy: axon dysfunction.
    Sima AA; Zhang W
    Handb Clin Neurol; 2014; 126():429-42. PubMed ID: 25410237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid metabolism in health and disease: the role of delta-6-desaturase.
    Horrobin DF
    Am J Clin Nutr; 1993 May; 57(5 Suppl):732S-736S; discussion 736S-737S. PubMed ID: 8386433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of metabolic disorders in the pathogenesis of diabetic neuropathy].
    Genes VS; Genes SG
    Klin Med (Mosk); 1981 Jan; 59(1):15-20. PubMed ID: 7017258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.